Marksans Pharma
MARKSANS.NS
#5474
Rank
NZ$2.69 B
Marketcap
NZ$5.95
Share price
-2.92%
Change (1 day)
53.64%
Change (1 year)

Earnings for Marksans Pharma (MARKSANS.NS)

Earnings in 2026 (TTM): NZ$0.14 Billion

According to Marksans Pharma 's latest financial reports the company's current earnings are NZ$0.36 Billion. In 2025 the company made an earning of NZ$0.10 Billion a decrease over its 2024 earnings that were of NZ$0.10 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Marksans Pharma from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.14 B40.78%
2025 NZ$0.10 B-4.7%
2024 NZ$0.10 B13.74%
2023 NZ$95.13 M42.13%
2022 NZ$66.93 M-7.29%
2021 NZ$72.19 M11.05%
2020 NZ$65.01 M106.8%
2019 NZ$31.43 M37.32%
2018 NZ$22.89 M33.95%
2017 NZ$17.09 M175.6%
2016 NZ$6.2 M-85.02%
2015 NZ$41.4 M-7.36%
2014 NZ$44.69 M24.21%
2013 NZ$35.98 M